Membrane cofactor protein (MCP; CD46): Isoforms differ in protection against the classical pathway of complement

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4415-4421

  Liszewski, M Kathryn ^a   Atkinson, John P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4B; MEMBRANE COFACTOR PROTEIN;

ARTICLE; CELL PROTECTION; COMPLEMENT ACTIVATION; GENE EXPRESSION; GLYCOSYLATION; HOST CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; RNA SPLICING; STREPTOCOCCUS PYOGENES; TISSUE SPECIFICITY; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; CHO CELLS; COMPLEMENT C4B; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT PATHWAY, CLASSICAL; CRICETINAE; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; TRANSFECTION;

EID: 0029946933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431.
2. Liszewski, M. K., and J. P. Atkinson. 1996. Membrane cofactor protein (CD46) and decay-accelerating factor (CD55). In The Complement System, 3rd Ed. K. Rother, G. Till and G. M. Hansch, eds. Springer-Verlag, New York. In press.
3. Liszewski, M. K., T. C. Farries, D. M. Lublin, I. A. Rooney, and J. P. Atkinson. 1996. Control of the complement system. Adv. Immunol. 61:201.
4. Seya, T., and J. P. Atkinson. 1989. Functional properties of membrane cofactor protein of complement. Biochem. J. 64:581.
5. Oglesby, T. J., C. J. Allen, M. K. Liszewski, D. J. G. White, and J. P. Atkinson. 1992. Membrane cofactor protein (MCP; CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. Exp. Med. 175:1547.
6. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025.
7. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonton strain). Cell 75:295.
8. Manchester, M., M. K. Liszewski, J. P. Atkinson, and M. B. A. Oldstone. 1994. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA 91:2161.
9. Dorig, R. E., A. Marcil, and C. D. Richardson. 1994. CD46, a primate-specific receptor for measles virus. Trends Microbiol. 2:312.
10. Okada, N., M. K. Liszewski, J. P. Atkinson, and M. Caparon. 1995. Membrane cofactor protein (MCP; CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA 92:2489.
11. Anderson, D. J., A. F. Abbott, and R. M. Jack. 1993. The role of complement component C3b and its receptors in sperm-oocyte interaction. Proc. Natl. Acad. Sci. USA 90:10051.
12. Rooney, I. A., T. J. Oglesby, and J. P. Atkinson. 1993. Complement in human reproduction: activation and control. Immunol. Res. 12:276.
13. Hunt, J. S. and B. L. Hsi. 1990. Evasive strategies of trophoblast cells: selective expression of membrane antigens. Am. J. Reprod. Immunol. 23:57.
14. Rooney, I. A., M. K. Liszewski, and J. P. Atkinson. 1993. Using membrane-bound complement regulatory proteins to inhibit rejection. Xeno 1:29.
15. Cozzi, E., and D. J. G. White. 1995. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1:964.
16. Ryan, U. S. 1995. Complement inhibitory therapeutics and xenotransplantation. Nat. Med. 1:967.
17. Post, T. W., M. K. Liszewski, E. M. Adams, I. Tedja, E. A. Miller, and J. P. Atkinson. 1991. Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms which correlate with protein phenotype. J. Exp. Med. 174:93.
18. Russell, S. M., R. L. Sparrow, I. F. C. McKenzie, and D. F. J. Purcell. 1992. Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur. J. Immunol. 22:1513.
19. Johnstone, R. W., S. M. Russell, B. E. Loveland, and I. F. C. McKenzie. 1993. Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol. Immunol. 30:1231.
20. Gorelick, A., T. J. Oglesby, W. Rashbaum, J. P. Atkinson, and J. P. Buyon. 1995. Ontogeny of membrane cofactor protein: phenotypic divergence in the fetal heart. Lupus 4:293.
21. Seya, T., L. L. Ballard, N. S. Bora, V. Kumar, W. Cui, and J. P. Atkinson. 1988. Distribution of membrane cofactor protein (MCP) of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur. J. Immunol. 18:1289.
22. Cervoni, F., T. J. Oglesby, M. Nickells, C. Milesi-Fluet, P. Fenichel, J. P. Atkinson, and B. L. Hsi. 1992. Identification and characterization of membrane cofactor protein (MCP) on human spermatozoa. J. Immunol. 148:1431.
23. Seya, T., T. Hara, M. Matsumoto, H. Kiyohara, I. Nakanishi, T. Kinouchi, M. Okabe, A. Shimizu, and H. Akedo. 1993. Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and "sterile" subjects. Eur. J. Immunol. 23:1322.
24. Liszewski, M. K., I. Tedja, and J. P. Atkinson. 1994. Membrane cofactor protein (CD46) of complement: processing differences related to alternatively spliced cytoplasmic domains. J. Biol. Chem. 269:10776.
25. Adams, E. M., M. C. Brown, M. Nunge, M. Krych, and J. P. Atkinson. 1991. Contribution of the repeating domains of membrane cofactor protein (MCP; CD46) of the complement system to ligand binding and cofactor activity. J. Immunol. 147:3005.
26. Oglesby, T. J., D. White, I. Tedja, M. K. Liszewski, L. Wright, J. Van den Bogarde, and J. P. Atkinson. 1991. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein (MCP) and decay-accelerating factor (DAF). Trans. Assoc. Am. Physicians 104:164.
27. Lublin, D. M., and K. E. Coyne. 1991. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J. Exp. Med. 174:35.
28. Loveland, B. E., R. W. Johnstone, S. M. Russell, B. R. Thorley, and I. F. C. McKenzie. 1993. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement-mediated lysis. Transpl. Immunol. 1:101.
29. Kojima, A., K. Iwata, T. Seya, M. Matsumoto, H. Ariga, J. P. Atkinson, and S. Nagasawa. 1993. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J. Immunol. 151:1519.
30. Ballard, L., T. Seya, J. Teckman, D. M. Lublin, and J. P. Atkinson. 1987. A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70). J. Immunol. 138:3850.
31. Johnstone, R. W., B. E. Loveland, and I. F. C. McKenzie. 1993. Identification and quantification of complement regulator CD46 on normal human tissue. Immunology 79:341.
32. Nakanishi, I., A. Moutabarrik, T. Hara, M. Hatanaka, T. Hayashi, T. Syouji, N. Okada, E. Kitamura, Y. Tsubakihara, and M. Matsumoto. 1994. Identification and characterization of membrane cofactor protein (CD46) in the human kidneys. Eur. J. Immunol. 24:1529.
33. Ichida, S., Y. Yuzawa, H. Okada, K. Yoshioka, and S. Matsuo. 1994. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int. 46:89.
34. Zwirner, J., E. Felber, R. Burger, D. Bitter-Suermann, G. Riethmuller, and H. E. Feucht. 1993. Classical pathway of complement activation in mammalian kidneys. Immunology 80:162.
35. Zwirner, J., E. Felber, V. Herzog, G. Riethmuller, and H. E. Feucht. 1989. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int. 36:1069.
36. Cosio, F. G., T. Shibata, B. H. Rovin, and D. J. Birmingham. 1994. Effects of complement activation products on the synthesis of decay-accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int. 46:986.
37. Endoh, M., M. Yamashina, H. Ohi, K. Funahashi, T. Ikuno, T. Yasugi, J. P. Atkinson, and H. Okada. 1993. Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues. Clin. Exp. Immunol. 94:182.
38. Lee, L. A., S. Coulter, S. Erner, and H. Chu. 1987. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies. Am. J. Med. 83:793.
39. Taylor, P. V., J. S. Scott, L. M. Gerlis, E. Esscher, and O. Scott. 1986. Maternal antibodies against fetal cardiac antigens in congenital complete heart block. N. Engl. J. Med 315:667.
40. Litsey, S. E., J. A. Noonan, W. N. O'Connor, C. M. Cottrill, and B. Mitchell. 1985. Maternal connective tissue disease and congenital heart block: demonstration of immunoglobulin in cardiac tissue. N. Engl. J. Med. 312:98.
41. Ballard, L. L., N. S. Bora, G. H. Yu, and J. P. Atkinson. 1988. Biochemical characterization of membrane cofactor protein of the complement system. J. Immunol. 141:3923.
42. Iwata, K., T. Seya, Y. Yanagi, J. M. Pesando, P. M. Johnson, M. Okabe, S. Ueda, H. Ariga, and S. Nagasawa. 1995. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem. 270:15148.
43. Coyne, K. E., S. E. Hall, S. Thompson, M. A. Arce, T. Kinoshita, T. Fujita, D. J. Anstee, W. Rosse, and D. M. Lublin. 1992. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay-accelerating factor. J. Immunol. 149:2906.
44. Kozarsky, K., D. Kingsley, and M. Krieger. 1988. Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA 85:4335.
45. Kojima, N., K. Handa, W. Newman, and S. Hakomori. 1992. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem. Biophys. Res. Commun. 182:1288.
46. Kuan, S. F., J. C. Byrd, C. Basbaum, and Y. S. Kim. 1989. Inhibition of mucin glycosylation by aryl-N-acetyl-α-galactosaminides in human colon cancer cells. J. Biol. Chem. 264:19271.